WEBINAR – ADC Developability for successful lead candidate selection
22 September 2021
We are doing a webinar on the 22nd September at 3pm BST/10am EDT. Register for the webinar here. Antibody-drug conjugates (ADCs) are fast becoming an established class of biopharmaceuticals with therapeutic applications in oncology and beyond. ADCs combine a monoclonal antibody conjugated to a highly potent cytotoxic payload via a suitable linker, that targets an […] Read more
WADC London 2022
29 March 2022
Our team, Nicolas Camper, Jonathan Cruickshank, Swati Chatterjee, Patrick Haddad and Mark Frigerio are excited to be attending World ADC London 2022 – Europe’s longest-standing and definitive antibody-drug conjugate event! This hybrid event offers an exciting opportunity to explore novel linker-payloads, overcoming critical in vivo and translational difficulties and so much more. Our very own Mark Frigerio will be hosting a talk on […] Read more